Get the Stockscreener App
3.45
3.29%
0.11
After Hours:
3.44
-0.01
-0.29%
Puma Biotechnology Inc Stock (PBYI) Latest News
Puma Biotechnology (PBYI): One of the Best Short-Term Stocks to Buy Right Now - Yahoo Finance
Checking in on Puma Biotechnology Inc (PBYI) after recent insiders movement - Knox Daily
Rhumbline Advisers Lowers Holdings in Puma Biotechnology, Inc. (NASDAQ:PBYI) - Defense World
Puma Biotechnology, Inc. (NASDAQ:PBYI) Held Back By Insufficient Growth Even After Shares Climb 26% - Simply Wall St
Puma Biotechnology (NASDAQ:PBYI) Rating Lowered to Buy at StockNews.com - Armenian Reporter
Puma Biotechnology (NASDAQ:PBYI) Stock Rating Lowered by StockNews.com - Defense World
We Think Puma Biotechnology's (NASDAQ:PBYI) Healthy Earnings Might Be Conservative - Yahoo Finance
Puma Biotech grants stock award to new hire By Investing.com - Investing.com Australia
Puma Biotechnology, Inc. to Host Earnings Call - ACCESS Newswire
Puma Biotechnology to Present at Barclays 27th Annual Global Healthcare Conference - BioSpace
Puma Biotech grants stock award to new hire - Investing.com India
Puma Biotechnology to Present at Barclays Annual Global Healthcare Conference - BioSpace
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance
Can Puma Biotechnology's Conference Presentation Signal New Growth Opportunities? - StockTitan
Puma Biotechnology’s Earnings Call: Mixed Sentiments and Future Outlook - MSN
Puma Biotechnology’s (PBYI) Buy Rating Reiterated at HC Wainwright - Defense World
Results: Puma Biotechnology, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates - Yahoo Finance UK
PBYI Stock Rises as Q4 Earnings & Sales Outpace Estimates - Nasdaq
Puma Biotechnology: Strong Financial Performance and Strategic Developments Justify Buy Rating - TipRanks
GoodRx Holdings Leads The Charge With These 3 Promising Penny Stocks - Simply Wall St
Puma Biotechnology, Inc. (NASDAQ:PBYI) Q4 2024 Earnings Call Transcript - Insider Monkey
Puma Biotechnology Inc (PBYI) Q4 2024 Earnings Call Highlights: Revenue Growth and Strategic ... By GuruFocus - Investing.com Canada
Puma Biotechnology Reports Fourth Quarter and Full Year 2024 Financial Results - sharewise
Puma Biotechnology Reports Strong Earnings Growth in 2024 - TipRanks
Puma Biotech: Q4 Earnings Snapshot - CTPost
Puma Biotechnology: Hold Rating Amidst Flat Sales Growth and Uncertain Drug Prospects - TipRanks
Puma Biotechnology, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024 - Marketscreener.com
Earnings call transcript: Puma Biotech Q4 2024 beats earnings expectations By Investing.com - Investing.com South Africa
Puma Biotech (PBYI) Q4 Earnings and Revenues Beat Estimates - Yahoo Finance
Earnings call transcript: Puma Biotech Q4 2024 beats earnings expectations - Investing.com
Puma Biotech stock rises as Q4 earnings surpass expectations By Investing.com - Investing.com Canada
Puma Biotech stock rises as Q4 earnings surpass expectations - Investing.com
Puma Biotechnology Boosts Profits 57% While Revenue Dips: What's Behind This Earnings Paradox? - StockTitan
Puma Biotechnology to Present at TD Cowen’s 45th Annual Health Care Conference - BioSpace
Puma Biotechnology Reveals Corporate Strategy at Major Healthcare ConferenceWhat Will CEO Disclose? - StockTitan
Puma Biotechnology Inc expected to post earnings of 10 cents a shareEarnings Preview - TradingView
Investors in Puma Biotechnology (NASDAQ:PBYI) have unfortunately lost 73% over the last five years - Yahoo Finance
Puma Biotechnology (PBYI) Projected to Post Quarterly Earnings on Thursday - Defense World
SG Americas Securities LLC Boosts Stock Position in Puma Biotechnology, Inc. (NASDAQ:PBYI) - Defense World
Puma Biotechnology to Host Conference Call to Discuss Fourth Quarter and Full Year 2024 Financial Results - BioSpace
Puma Biotech's Crucial Full Year Earnings Reveal: Q4 Financial Results Coming February 27 - StockTitan
Inside Puma Bio's Latest Executive Compensation Move: Key Details on RSU Grants - StockTitan
Millennium Management LLC Reduces Stake in Puma Biotechnology Inc - GuruFocus.com
JPMorgan Chase & Co. Acquires 30,499 Shares of Puma Biotechnology, Inc. (NASDAQ:PBYI) - Defense World
Puma commences Phase II trial of alisertib for breast cancer treatment - MSN
US Penny Stocks To Watch In January 2025 - Simply Wall St
Zacks Research Analysts Increase Earnings Estimates for PBYI - Defense World
What is Zacks Research's Forecast for PBYI FY2025 Earnings? - MarketBeat
2.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):